Consolidated Income Statement

Sales

2,721.7

2,434.3

8,028.7

7,381.4

Royalty, license and commission income

119.4

97.3

309.4

269.3

Total revenues

2,841.0

2,531.6

8,338.1

7,650.7

Cost of sales

–787.6

–679.1

–2,344.1

–2,077.9

Gross profit

2,053.4

1,852.5

5,994.0

5,572.8

Marketing and selling expenses

–598.0

–584.6

–1,801.8

–1,778.5

Royalty, license and commission expenses

–161.6

–133.9

–433.4

–363.7

Administration expenses

–141.6

–132.6

–420.6

–397.1

Other operating expenses and income

–245.1

–86.3

–878.4

–301.5

Research and development

–370.8

–370.2

–1,156.5

–1,117.3

Amortization of intangible assets

–218.2

–212.9

–651.8

–780.1

Investment result

–

–0.1

0.5

1.9

Operating result (EBIT)

318.1

331.8

651.9

836.4

Financial result

–58.2

–72.4

–193.9

–219.0

Profit before income tax

260.0

259.4

458.0

617.5

Income tax

–71.3

–32.3

–154.7

–135.6

Profit after tax

188.7

227.2

303.3

481.9

of which attributable to Merck KGaA shareholders (net income)

185.5

223.9

294.9

473.6

of which non-controlling interest

3.2

3.3

8.3

8.2

Earnings per share (in €)

basic

0.85

1.03

1.36

2.18

diluted

0.85

1.03

1.36

2.18